Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist

Blood

Volumn 102, Issue 8, 2003, Pages 2728-2730

  Liles, W Conrad ^b   Broxmeyer, Hal E ^b   Rodger, Elin ^b   Wood, Brent ^b   Hübel, Kai ^b   Cooper, Scott ^b   Hangoc, Giao ^b   Bridger, Gary J ^b   Henson, Geoffrey W ^b   Calandra, Gary ^b   Dale, David C ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); CD34 ANTIGEN; CHEMOKINE RECEPTOR CXCR4;

ABDOMINAL DISTENSION; ADULT; ANTIGEN DETECTION; ARTICLE; BLOOD; BONE MARROW; CELL COUNT; COLONY FORMING UNIT; CONTROLLED STUDY; DOSE RESPONSE; DRUG TOLERABILITY; ERYTHEMA; FEMALE; HEADACHE; HEALTH STATUS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; INJECTION SITE; LEUKOCYTOSIS; MALE; NAUSEA; NORMAL HUMAN; PARESTHESIA; PERIORAL PARESTHESIA; PRIORITY JOURNAL; SIDE EFFECT; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; UNPLEASANT SENSATION; VOLUNTEER;

EID: 0141923918     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-02-0663     Document Type: Article

References (28)

1. Nagasawa T. A chemokine, SDF-1/PBSF, and its receptor, CXC chemokine receptor 4, as mediators of hematopoiesis. Int J Hematol. 2000;72: 408-411.
2. Nagasawa T, Kikutani H, Kishimoto T. Molecular cloning and structure of a pre-B-cell growth-stimulating factor. Proc Natl Acad Sci U S A. 1994;91:2305-2309.
3. Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med. 1996;184:1101-1109.
4. Lee Y, Gotoh A, Kwon HJ, et al. Enhancement of intracellular signaling associated with hematopoietic progenitor cell survival in response to SDF-1/CXCL12 in synergy with other cytokines. Blood. 2002;99:4307-4317.
5. + progenitors to peripheral blood. J Exp Med. 1997;185:111-120.
6. Aiuti A, Tavian M, Cipponi A, et al. Expression of CXCR4, the receptor for stromal cell-derived factor-1 on fetal and adult human lympho-hematopoietic progenitors. Eur J Immunol. 1999;29: 1823-1831.
7. + hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood. 1998;91:4523-4530.
8. Kim CH, Broxmeyer HE. In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants; stromal cell-derived factor-1, Steel factor, and the bone marrow environment. Blood. 1998;91:100-110.
9. + hematopoietic stem cells. Ann Hematol. 1998;77:193-197.
10. Peled A, Petit I, Kollet O, et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science. 1999;283: 845-848.
11. Rosu-Myles M, Gallacher L, Murdoch B, et al. The human hematopoietic stem cell compartment is heterogeneous for CXCR4 expression. Proc Natl Acad Sci U S A. 2000;97:14626-14631.
12. + cell proliferation in synergy with cytokines: possible role in progenitor survival. Blood. 2000;95:756-768.
13. Ma Q, Jones D, Springer TA. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity. 1999; 10;463-471.
14. Bleul CC, Farzan M, Choe H, et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature. 1996;382:829-833.
15. + hematopoietic progenitor cells. Blood. 1997;89:3522-3588.
16. Sachpatzidis A, Benton BK, Manfredi JP, et al. Identification of allosteric peptide agonists of CXCR4. J Biol Chem. 2003;278:896-907.
17. Hatse S. Princen K. Bridger G. De Clercq E. Schols D. Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4. FEBS Lett. 2002;527:255-262.
18. Hendrix CW, Flexner C, MacFarland RT, et al. Pharmacokinetics and safety of AMD3100, a novel antagonist of the CXCR-4 chemokine receptor, receptor, in human volunteers. Antimicrob Agents Chemother. 2000;44:1667-1673.
19. Gerlach LO, Skerlj RT, Bridger GJ, Schwartz TW. Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor. J Biol Chem. 2001;276:14153-14160.
20. Zhang WB, Navenot JM, Haribabu B, et al. A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C are weak partial agonists. J Biol Chem. 2002;277:24515-24521.
21. + cell counts based on the ISHAGE guidelines: International Society of Hematotherapy and Graft Engineering. Cytometry. 1998;34:286-288.
22. Cooper S, Broxmeyer HE. Measurement of interleukin-3 and other hematopoietic growth factors, such as GM-CSF, G-CSF, M-CSF, erythropoietin and the potent co-stimulating cytokines steel factor and Flt-3 ligand. In: Coligan JE, Kruisbeek AM, Margolies DH, et al, eds. Current Protocols in Immunology. New York, NY: John Wiley & Sons; 1996:18:6.4.1-18:6.4.12.
23. Broxmeyer HE, Cooper S, Vadhan-Raj S. Cell cycle status of erythroid (BFU-E) progenitor cells from the bone marrows of patients on a clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor. Exp Hematol. 1989;17:455-459.
24. Bensinger W, Appelbaum F, Rowley S, et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol. 1995;13:2547-2555.
25. Lane TA, Ho AD, Bashey A, Peterson S, Young D, Law P. Mobilization of blood-derived stem and progenitor cells in normal subjects by granulocyte-macrophage- and granulocyte-colony-stimulating factors. Transfusion. 1999;39:39-47.
26. Korbling M, Anderlini P. Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter? Blood. 2001;98:2900-2908.
27. Lapidot T, Petit I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol. 2002;30:973-981.
28. Liles WC, Broxmeyer HE, Rodger E, et al. Leukocytosis and mobilization of pluripotent hematopoietic progenitor cells in healthy volunteers induced by single dose administration of AMD-3100, a CXCR4 antagonist [abstract]. Blood. 2001;98: 737a.